SMAD3 and metabolic disease: Considerable evidence demonstrates that the activation of Smad3 signalling correlates closely with the severity of metabolic diseases like obesity and diabetes in mice and humans.31, 34 However, the role played by Smad3 signalling in acute neural injury complicated with diabetes remained unclear.